Yongtao Guo1, Shuai Zhang2, Mingchao Li3, Bo Sun1, Xianjin Shang4, Shun Li5, Yongjie Bai6, Zibao Li4, Wenjie Zi7, Xinfeng Liu8. 1. Department of Neurology, Jinling Clinical College of Nanjing Medical University, 305 East Zhongshan Road, 210002 Nanjing, Jiangsu, China; Department of Neurology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Nanjing Medical University, 223300 Huai'an, Jiangsu, China. 2. Department of Neurology, Jinling Clinical College of Nanjing Medical University, 305 East Zhongshan Road, 210002 Nanjing, Jiangsu, China; Department of Neurology, the Affiliated Hospital of Yangzhou University, Yangzhou University, 225001 Yangzhou, Jiangsu, China. 3. Department of Neurology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Nanjing Medical University, 223300 Huai'an, Jiangsu, China. 4. Department of Neurology, Jinling Clinical College of Nanjing Medical University, 305 East Zhongshan Road, 210002 Nanjing, Jiangsu, China; Department of Neurology, Yijishan Hospital of Wannan Medical College, 241001 Wuhu, Anhui, China. 5. Department of Neurology, Jinling Hospital, Southern Medical University, 210002 Nanjing, Jiangsu, China. 6. Department of Neurology, Jinling Clinical College of Nanjing Medical University, 305 East Zhongshan Road, 210002 Nanjing, Jiangsu, China; Department of Neurology, First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, 471003 Luoyang, China. 7. Department of Neurology, Jinling Clinical College of Nanjing Medical University, 305 East Zhongshan Road, 210002 Nanjing, Jiangsu, China. Electronic address: ziwenjie1981@163.com. 8. Department of Neurology, Jinling Clinical College of Nanjing Medical University, 305 East Zhongshan Road, 210002 Nanjing, Jiangsu, China; Department of Neurology, Jinling Hospital, Southern Medical University, 210002 Nanjing, Jiangsu, China. Electronic address: xfliu2@vip.163.com.
Abstract
BACKGROUND AND PURPOSE: The aim of the study was to evaluate whether leukoaraiosis (LA) severity is associated with earlier neurological outcome in acute stroke patients undergoing mechanical thrombectomy. MATERIALS AND METHODS: In this retrospective multicenter study, we evaluated 273 acute stroke patients treated with mechanical thrombectomy. LA severity was graded as 0-2 (absent-to-moderate) versus 3-4 (severe) according to the van Swieten scale. The main clinical outcome was the proportion of early neurological improvement and early neurological deterioration. Early neurological improvement was defined as a decrease of≥4 points on the NIHSS, or an NIHSS score of zero 24hours after baseline assessment. Early neurological deterioration was defined as an increase of≥4 points on the NIHSS 24hours after baseline assessment. RESULTS: There was a significantly lower early neurological improvement rate (17.1% versus 39.2%; P=0.006) and non-significantly higher early neurological deterioration rate (29.3% versus 17.7%; P=0.084) in patients with severe LA (sLA) compared with patients with absent-to-moderate LA. In multivariable analysis, sLA was inversely associated with early neurological improvement (OR, 0.31; 95% CI, 0.13-0.78; P=0.012). There was no significant association of sLA with early neurological deterioration. However, in patients without symptomatic intracranial hemorrhage, sLA was an independent predictor of early neurological deterioration (OR, 2.65; 95% CI, 1.09-6.45; P=0.032). CONCLUSIONS: sLA is a significant negative predictor of early neurological improvement and is an independent predictor of early neurological deterioration in patients without symptomatic intracranial hemorrhage.
BACKGROUND AND PURPOSE: The aim of the study was to evaluate whether leukoaraiosis (LA) severity is associated with earlier neurological outcome in acute strokepatients undergoing mechanical thrombectomy. MATERIALS AND METHODS: In this retrospective multicenter study, we evaluated 273 acute strokepatients treated with mechanical thrombectomy. LA severity was graded as 0-2 (absent-to-moderate) versus 3-4 (severe) according to the van Swieten scale. The main clinical outcome was the proportion of early neurological improvement and early neurological deterioration. Early neurological improvement was defined as a decrease of≥4 points on the NIHSS, or an NIHSS score of zero 24hours after baseline assessment. Early neurological deterioration was defined as an increase of≥4 points on the NIHSS 24hours after baseline assessment. RESULTS: There was a significantly lower early neurological improvement rate (17.1% versus 39.2%; P=0.006) and non-significantly higher early neurological deterioration rate (29.3% versus 17.7%; P=0.084) in patients with severe LA (sLA) compared with patients with absent-to-moderate LA. In multivariable analysis, sLA was inversely associated with early neurological improvement (OR, 0.31; 95% CI, 0.13-0.78; P=0.012). There was no significant association of sLA with early neurological deterioration. However, in patients without symptomatic intracranial hemorrhage, sLA was an independent predictor of early neurological deterioration (OR, 2.65; 95% CI, 1.09-6.45; P=0.032). CONCLUSIONS:sLA is a significant negative predictor of early neurological improvement and is an independent predictor of early neurological deterioration in patients without symptomatic intracranial hemorrhage.
Authors: Zimbul Albo; Jose Marino; Muhammad Nagy; Dilip K Jayaraman; Muhammad U Azeem; Ajit S Puri; Nils Henninger Journal: J Neurointerv Surg Date: 2020-05-15 Impact factor: 5.836